Compare MRCY & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRCY | NOVT |
|---|---|---|
| Founded | 1981 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 5.7B |
| IPO Year | 1997 | 1999 |
| Metric | MRCY | NOVT |
|---|---|---|
| Price | $114.74 | $146.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 1 |
| Target Price | $80.00 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 653.6K | 563.9K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.69 | N/A |
| EPS | N/A | ★ 0.51 |
| Revenue | ★ $912,020,000.00 | $521,290,000.00 |
| Revenue This Year | $6.59 | $8.61 |
| Revenue Next Year | $9.56 | $6.57 |
| P/E Ratio | ★ N/A | $289.86 |
| Revenue Growth | 9.19 | ★ 35.49 |
| 52 Week Low | $49.87 | $98.27 |
| 52 Week High | $128.45 | $171.85 |
| Indicator | MRCY | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 53.10 | 40.53 |
| Support Level | $71.15 | $131.26 |
| Resistance Level | $122.17 | $149.42 |
| Average True Range (ATR) | 6.69 | 7.17 |
| MACD | 0.05 | -0.85 |
| Stochastic Oscillator | 45.63 | 6.04 |
Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.